Structural Basis for Shieldin Complex Subunit 3–Mediated Recruitment Of

Total Page:16

File Type:pdf, Size:1020Kb

Structural Basis for Shieldin Complex Subunit 3–Mediated Recruitment Of ARTICLE cro Structural basis for shieldin complex subunit 3–mediated recruitment of the checkpoint protein REV7 during DNA double-strand break repair Received for publication, October 12, 2019, and in revised form, November 27, 2019 Published, Papers in Press, December 3, 2019, DOI 10.1074/jbc.RA119.011464 Yaxin Dai‡§, Fan Zhang¶, Longge Wang‡§, Shan Shan‡, X Zihua Gong¶1, and X Zheng Zhou‡§2 From the ‡National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China, the §Institute of Biophysics, University of Chinese Academy of Sciences, Beijing 100049, China, and the ¶Department of Cancer Biology, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio 44195 Edited by Patrick Sung Shieldin complex subunit 3 (SHLD3) is the apical subunit of a properly repaired. In vertebrate cells, two main repair path- recently-identified shieldin complex and plays a critical role in ways, nonhomologous end-joining (NHEJ) and homologous DNA double-strand break repair. To fulfill its function in recombination (HR), are employed in eliminating the cytotoxic Downloaded from DNA repair, SHLD3 interacts with the mitotic spindle assembly DSBs and thereby ensuring genomic integrity (1, 2). The deci- checkpoint protein REV7 homolog (REV7), but the details of sion-making process of repair pathways is a critical step during this interaction remain obscure. Here, we present the crystal DSB response, which involves several elements such as the cell structures of REV7 in complex with SHLD3’s REV7-binding cycle state, the epigenetic regulation, and the DNA end resec- domain (RBD) at 2.2–2.3 Å resolutions. The structures revealed tion (3, 4). 53BP1, in concert with its upstream regulators and http://www.jbc.org/ that the ladle-shaped RBD in SHLD3 uses its N-terminal loop downstream effectors, spearheads the restriction of end resection and C-terminal ␣-helix (␣C-helix) in its interaction with REV7. to promote NHEJ and antagonizes BRCA1-mediated HR repair, The N-terminal loop exhibited a structure similar to those pre- whose initiation step relies on resected DNA termini (5–14). viously identified in other REV7-binding proteins, and the less- Recently, several elegant studies have identified a previously-un- conserved ␣C-helix region adopted a distinct mode for binding characterized protein complex, named Shieldin, working as a at Inst Biophys, CAS on February 23, 2020 REV7. In vitro and in vivo binding analyses revealed that the downstream effector of 53BP1 to protect DNA end from resection N-terminal loop and the ␣C-helix are both indispensable and to facilitate NHEJ repair in a 53BP1-dependent manner (15– for high-affinity REV7 binding (with low-nanomolar affinity), 21). Similar to loss of 53BP1, deficient Shieldin leads to reactiva- underscoring the crucial role of SHLD3 ␣C-helix in protein tion of end resection, impairs NHEJ activities, and affects the binding. Moreover, binding kinetics analyses revealed that the immunoglobulin class switching process (22). REV7 “safety belt” region, which plays a role in binding other Shieldin consists of four subunits: SHLD3 (also known as proteins, is essential for SHLD3–REV7 binding, as this region CTC-534A2.2 or RINN1); SHLD2 (also known as FAM35A or retards the dissociation of the RBD from the bound REV7. RINN2); SHLD1 (also known as C20ORF196 or RINN3); and Together, the findings of our study reveal the molecular basis of REV7 (also known as MAD2L2). Apart from REV7, the other three the SHLD3–REV7 interaction and provide critical insights into Shieldin components had not been characterized before. Among how SHLD3 recognizes REV7. these subunits, SHLD3 is the most apical element (16, 19, 22) that bridges REV7 to RIF1 and fills the gap in the 53BP1–RIF1–REV7 3 axis. Therefore, SHLD3 and REV7 form a sub-complex, which is DNA double-strand breaks (DSBs) are extremely vicious considered as the DSB-recruitment module, while SHLD2, along DNA lesions that may cause carcinogenesis or cell death if not with SHLD1, functions as the ssDNA-binding module within the complex (16). Knockdown of SHLD3 largely reduced the localiza- This work was supported by Chinese Ministry of Science and Technology Grant 2019YFA0508902 (to Z. Z.), Natural Science Foundation of China tion intensities of REV7/SHLD2/SHLD1 to the ionizing radiation- Grants 31970621 (to S. S.) and 31521002 and 31671344 (to Z. Z.), Strategic induced foci region, highlighting its RIF1-proximal role (16, 19). Priority Research Program Grant XDB0 8010104 (to Z. Z.), Ovarian Cancer Importantly, depletion of SHLD3 dampens NHEJ-related events, Research Fund Alliance Grant 605101 (to Z. G.), and National Institutes of Health NCI Grant CA222195 (to Z. G.). The authors declare that they have activates DNA end resection, and restores HR in a BRCA1-mu- no conflicts of interest with the contents of this article. The content is solely tated context, thus rendering these cells poly(ADP-ribose) poly- the responsibility of the authors and does not necessarily represent the merase inhibitors–resistant (15, 16, 19). Although SHLD3 is official views of the National Institutes of Health. essential for recruitment and function of Shieldin by directly inter- This article contains Figs. S1–S4. The atomic coordinates and structure factors (codes 6K07 and 6K08) have been acting with REV7, the underlying molecular mechanism remains deposited in the Protein Data Bank (http://wwpdb.org/). elusive. 1 To whom correspondence may be addressed. E-mail: [email protected]. 2 To whom correspondence may be addressed. E-mail: [email protected]. 3 The abbreviations used are: DSB, double-strand break; RBD, REV7-binding DNA; RBM, REV7-binding motif; IMAC, immobilized metal-affinity domain; PDB, Protein Data Bank; NHEJ, nonhomologous end-joining; HR, chromatography; Ni-NTA, nickel-nitrilotriacetic acid; IPTG, isopropyl ␤-D- homologous recombination; ITC, isothermal titration calorimetry; MBP, thiogalactoside; TLS, translesion DNA synthesis; CAMP, chromosome maltose-binding protein; SPR, surface plasmon resonance; RMSD, root alignment–maintaining phosphoprotein; SFB, S protein, FLAG, and mean square deviation; ␣C-helix, C-terminal ␣-helix; ssDNA, single-strand streptavidin-binding peptide tag. 250 J. Biol. Chem. (2020) 295(1) 250–262 © 2020 Dai et al. Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc. Structural insights into REV7 recruitment by SHLD3 In this study, we report two crystal structures of REV7 in affinity as SHLD3(29–83) with a dissociation constant of complex with the SHLD3–RBD. The complex structure shows 15.7 Ϯ 0.8 nM in ITC measurement (Fig. 1b), indicating that the that SHLD3–RBD forms a “ladle” configuration when it binds amino acid residues ranging from 29 to 45 of SHLD3, although to REV7, comprising the N-terminal loop and the C-terminal conserved, are dispensable for REV7 interaction. Therefore, we ␣-helix (␣C-helix) of SHLD3–RBD, which constitute the cor- named residues 46–74 of SHLD3 as the RBD and purified the responding “stem” and “base” part of the ladle-shaped struc- REV7–SHLD3 (RBD) complex for the next round of crystal ture. The N-terminal loop is structurally similar to other REV7- screening. Encouragingly, the REV7–SHLD3 (RBD) complex binding proteins due to the presence of a well-established yielded diffraction-quality crystals. REV7-binding motif, but the ␣C-helix displays a binding mode distinct from known REV7-binding partners. Biochemical anal- Overall structure of the SHLD3–REV7 complex yses, coupled with thermodynamic measurements, have veri- The structures of the REV7R124A–SHLD3 (RBD) and fied their contribution to REV7 binding. Importantly, we dem- REV7R124A, A135D–SHLD3 (RBD) complex were determined by onstrated that the ␣C-helix region of SHLD3–RBD is a crucial the molecular replacement method using 2.2 and 2.3 Å resolu- contributing factor of robust SHLD3–REV7 interaction. Addi- tion data, respectively. Both crystals contain one single copy of tionally, we present the first kinetic view on the “safety-belt” the SHLD3–REV7 complex per asymmetric unit, and residues binding mechanism underlying the SHLD3–REV7 complex via 9–207 of REV7 and 49–73 of SHLD3 were successfully mod- surface plasmon resonance (SPR) assays. In sum, this work is eled, whereas other residues were not included in the final mod- Downloaded from the first structural study toward the role of REV7 in DSB repair els due to indiscernible electron density. The crystallographic and provides structural insights into how the DSB recruitment and geometric statistics of the refined models are exhibited in module assembles within the Shieldin complex. Table 1. Because these two structures are nearly identical, the REV7R124A–SHLD3 (RBD) structure with higher resolution Results was chosen as a representative for further description. Within the structure, REV7 displays a canonical HORMA http://www.jbc.org/ SHLD3 employs REV7-binding domain to interact with REV7 (Hop1, Rev7, and Mad2) fold and adopts the closed conforma- SHLD3 is a 250-amino acid polypeptide with a translational tion with SHLD3 peptide tightly held by the safety-belt loop of elongation initiation factor EIF4E-like domain in its C terminus REV7 (Fig. 1c). Superimposition of REV7 in our complex with (15) and contains two presumptive REV7-binding motifs the previously reported structures of REV7/REV3–RBM1 (PDB (RBM, defined by PXXXpP sequence, where X represents any code 3ABD) (24), REV7/CAMP (PDB code 5XPT) (26), and at Inst Biophys, CAS on February 23, 2020 amino acid residue and the lowercase p is a less important pro- REV7/REV3–RBM2 (PDB code 6BC8) (25) revealed overall line residue and can be replaced by an alanine in some cases) in root mean square deviation (RMSD) values of 0.830, 0.953, and the N-terminal region (Fig. 1a). Previous work has mapped the 0.915 Å, respectively, suggesting the global similarity of REV7 region (residues 29–83), which harbors the second RBM in the molecules in these protein complexes, except for some zones N-terminal region of SHLD3 that interacts with REV7 (19).
Recommended publications
  • Identification of Conserved Genes Triggering Puberty in European Sea
    Blázquez et al. BMC Genomics (2017) 18:441 DOI 10.1186/s12864-017-3823-2 RESEARCHARTICLE Open Access Identification of conserved genes triggering puberty in European sea bass males (Dicentrarchus labrax) by microarray expression profiling Mercedes Blázquez1,2* , Paula Medina1,2,3, Berta Crespo1,4, Ana Gómez1 and Silvia Zanuy1* Abstract Background: Spermatogenesisisacomplexprocesscharacterized by the activation and/or repression of a number of genes in a spatio-temporal manner. Pubertal development in males starts with the onset of the first spermatogenesis and implies the division of primary spermatogonia and their subsequent entry into meiosis. This study is aimed at the characterization of genes involved in the onset of puberty in European sea bass, and constitutes the first transcriptomic approach focused on meiosis in this species. Results: European sea bass testes collected at the onset of puberty (first successful reproduction) were grouped in stage I (resting stage), and stage II (proliferative stage). Transition from stage I to stage II was marked by an increase of 11ketotestosterone (11KT), the main fish androgen, whereas the transcriptomic study resulted in 315 genes differentially expressed between the two stages. The onset of puberty induced 1) an up-regulation of genes involved in cell proliferation, cell cycle and meiosis progression, 2) changes in genes related with reproduction and growth, and 3) a down-regulation of genes included in the retinoic acid (RA) signalling pathway. The analysis of GO-terms and biological pathways showed that cell cycle, cell division, cellular metabolic processes, and reproduction were affected, consistent with the early events that occur during the onset of puberty.
    [Show full text]
  • Human Pol Ζ Purified with Accessory Subunits Is Active in Translesion DNA Synthesis and Complements Pol Η in Cisplatin Bypass
    Human Pol ζ purified with accessory subunits is active in translesion DNA synthesis and complements Pol η in cisplatin bypass Young-Sam Lee1, Mark T. Gregory, and Wei Yang2 Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892 Contributed by Wei Yang, December 27, 2013 (sent for review December 5, 2013) DNA polymerase ζ (Pol ζ) is a eukaryotic B-family DNA polymerase a nucleotide opposite either a cis–syn thymine or a 6-4 photo- that specializes in translesion synthesis and is essential for normal product (23). Genetic data indicate that a complete lesion bypass embryogenesis. At a minimum, Pol ζ consists of a catalytic subunit event may require two TLS DNA polymerases (24)—one for Rev3 and an accessory subunit Rev7. Mammalian Rev3 contains nucleotide incorporation opposite a lesion (insertion step) and >3,000 residues and is twice as large as the yeast homolog. To the other for the subsequent primer extension (extension step). date, no vertebrate Pol ζ has been purified for biochemical char- The insertion step of TLS is often accomplished by a Y-family acterization. Here we report purification of a series of human Rev3 polymerase, whose active site is uncommonly large, solvent- deletion constructs expressed in HEK293 cells and identification of exposed, and flexible (25). Studies of another B-family TLS DNA a minimally catalytically active human Pol ζ variant. With a tagged polymerase from Escherichia coli (Pol II) show that it efficiently form of an active Pol ζ variant, we isolated two additional acces- extends a DNA primer after a lesion by looping out the damaged sory subunits of human Pol ζ, PolD2 and PolD3.
    [Show full text]
  • Gene Section Review
    Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Review MAD2L1 (mitotic arrest deficient 2, yeast, human homolog like-1) Elizabeth M. Petty, Kenute Myrie Division of Medical Genetics Departments of Human Genetics and Internal Medicine University of Michigan Medical School 1150 West Medical Center Drive, 4301 MSRB III, Ann Arbor, Michigan 48109- 0638, USA (EMP, KM) Published in Atlas Database: March 2001 Online updated version : http://AtlasGeneticsOncology.org/Genes/MAD2L1ID304.html DOI: 10.4267/2042/37729 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2001 Atlas of Genetics and Cytogenetics in Oncology and Haematology Identity Other names: HsMAD2; MAD2; MAD2A HGNC (Hugo): MAD2L1 Shadded boxes (1-5) depict the 5 exons of MAD2L1. The black Location : 4q27 triangle indicates a del A mutation that was found in the CAL51 Local order: As noted on the GM99-GB4 breast cancer cell line. Open triangkes depict the locations of Chromosome 4 map: Position: 548.24 (cR3000) Lod identified sequence variants. Figure is not drawn to scale. score: 1.16 Reference Interval: D4S2945-D4S430 Transcription (115.1-125.1 cM) It is located within the NCBI BAC MAD2L1 has 5 coding exons. No alternative splicing genomic contig: NT_006302.2 which is part of the has been described. Regulation of its transcription in homo sapiens chromosome 4 sequence segment. human cells is currently poorly understood. Note: MAD2L1 was intially (and errounously) mapped by fluorescence in situ hybridization (FISH) to 5q23- Protein q31. Subsequent comprehensive mapping studies using somatic cell hybrid analysis, radiation hybrid (RH) Description mapping, and FISH localized it to 4q27.
    [Show full text]
  • Anti-MAD2L2 Monoclonal Antibody, Clone FQS24768 (DCABH-6886) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
    Anti-MAD2L2 monoclonal antibody, clone FQS24768 (DCABH-6886) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Product Overview Rabbit Monoclonal to Mad2L2 Antigen Description Adapter protein able to interact with different proteins and involved in different biological processes. Mediates the interaction between the error-prone DNA polymerase zeta catalytic subunit REV3L and the inserter polymerase REV1, thereby mediating the second polymerase switching in translesion DNA synthesis. Translesion DNA synthesis releases the replication blockade of replicative polymerases, stalled in presence of DNA lesions. May also regulate another aspect of cellular response to DNA damage through regulation of the JNK-mediated phosphorylation and activation of the transcriptional activator ELK1. Inhibits the FZR1- and probably CDC20-mediated activation of the anaphase promoting complex APC thereby regulating progression through the cell cycle. Regulates TCF7L2-mediated gene transcription and may play a role in epithelial-mesenchymal transdifferentiation. Immunogen Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human Mad2L2 aa 150 to the C-terminus. The exact sequence is proprietary.Database link: Q9UI95 Isotype IgG Source/Host Rabbit Species Reactivity Mouse, Rat, Human Clone FQS24768 Purity Protein A purified Conjugate Unconjugated Applications IP, ICC/IF, Flow Cyt, IHC-P, WB Positive Control K562, SW480, Hela, Molt-4 cell lysates, human ovarian carcinoma tissue, Hela cells, Format Liquid Size 100 μl Buffer Preservative: 0.01% Sodium azide; Constituents: 59% PBS, 0.05% BSA, 40% Glycerol 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved Preservative 0.01% Sodium Azide Storage Store at +4°C short term (1-2 weeks).
    [Show full text]
  • MAD2L2 Monoclonal ANTIBODY
    For Research Use Only MAD2L2 Monoclonal ANTIBODY www.ptgcn.com Catalog Number:67100-1-Ig Basic Information Catalog Number: GenBank Accession Number: CloneNo.: 67100-1-Ig BC015244 2A4C2 Size: GeneID (NCBI): Recommended Dilutions: 1000 μg/ml 10459 WB 1:5000-1:20000 Source: Full Name: IHC 1:500-1:2000 Mouse MAD2 mitotic arrest deficient-like 2 (yeast) Isotype: Calculated MW: IgG2b 211aa,24 kDa Purification Method: Observed MW: Protein A purification 24 kDa Immunogen Catalog Number: AG28233 Applications Tested Applications: Positive Controls: IHC, WB, ELISA WB : HeLa cells; Species Specificity: IHC : human lymphoma tissue; Human, mouse, rat Note-IHC: suggested angen retrieval with TE buffer pH 9.0; (*) Alternavely, angen retrieval may be performed with citrate buffer pH 6.0 MAD family, together with BUB and Mps1,Cdc20k, play roles in the mitotic spindle checkpoint. MAD2L2 is one of the MAD family. It can mediate the second Background Information polymerase switching in translation DNA synthesis by mediating the interaction between the error-prone DNA polymerase zeta catalytic subunit REV3L and the inserter polymerase REV1. Through regulation of the JNK-mediate phosphorylation and activation of the transcriptional activator ELK1, MAD2L2 involves in cellular response to DNA damage. Also it has role in the progression of cell cycle and peithelial-mesenchymal transdifferentiation. Storage: Storage Store at -20ºC. Stable for one year after shipment. Storage Buffer: PBS with 0.1% sodium azide and 50% glycerol pH 7.3. Aliquoting is unnecessary for -20ºC storage For technical support and original validation data for this product please contact: This product is exclusively available under T: 4006900926 E: [email protected] W: ptgcn.com Proteintech Group brand and is not available to purchase from any other manufacturer.
    [Show full text]
  • Shieldin Complex Promotes DNA End-Joining and Counters Homologous Recombination in BRCA1-Null Cells
    This is a repository copy of Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/136933/ Version: Accepted Version Article: Dev, H, Chiang, T-WW, Lescale, C et al. (27 more authors) (2018) Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells. Nature Cell Biology, 20. pp. 954-965. ISSN 1465-7392 https://doi.org/10.1038/s41556-018-0140-1 © 2018 Springer Nature Limited. This is an author produced version of a paper published in Nature Cell Biology. Uploaded in accordance with the publisher's self-archiving policy. Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ 1 Shieldin complex promotes DNA end-joining and counters 2 homologous recombination in BRCA1-null cells 3 4 Harveer Dev1,2, Ting-Wei Will Chiang1Y, Chloe Lescale3Y, Inge de Krijger4Y, Alistair G.
    [Show full text]
  • Mad2l2 As a Safeguard for Open Chromatin in Embryonic Stem Cells
    Mad2l2 as a safeguard for open chromatin in embryonic stem cells Dissertation for the award of the degree “Doctor rerum naturalium.” Of the Georg-August-Universität Göttingen within the doctoral program (Genes and Development) of the Georg-August University School of Science (GAUSS) Submitted by: Ali Rahjouei From: Iran Göttingen, 2016 1 Members of the Thesis Committee Reviewer 1: Professor Dr. Michael Kessel Developmental Biology Group, Max Planck Institute for Biophysical Chemistry Reviewer 2: Professor Dr. Wolfgang Fischle Biological and Environmental Sciences & Engineering Division, King Abdullah University of Science and Technology Professor Dr. Tomas Pieler Department of Developmental Biochemistry, University Medical Center Göttingen Members of the Extended Thesis Committee Professor Dr. Ahmed Mansouri Molecular Cell Differentiation Group, Max Planck Institute for Biophysical Chemistry Professor Dr. Detlef Doenecke Department of Molecular Biology, University Medical Center Göttingen Dr. Halyna Shcherbata Gene expression and signaling Biology Group, Max Planck Institute for Biophysical Chemistry Date of the oral June 2016 2 Affirmation: Here I declare that my doctoral thesis entitled “Mad2l2 as a safeguard for open chromatin in embryonic stem cells” has been written independently with no other sources and aids than quoted. Ali Rahjouei, Goettingen, April 2016 3 Contents Acknowledgment ...................................................................................................................................... 6 Summary .................................................................................................................................................
    [Show full text]
  • Cornelia De Lange Syndrome-Associated Mutations Cause a DNA Damage Signalling and Repair Defect
    ARTICLE https://doi.org/10.1038/s41467-021-23500-6 OPEN Cornelia de Lange syndrome-associated mutations cause a DNA damage signalling and repair defect Gabrielle Olley1, Madapura M. Pradeepa 1,2, Graeme R. Grimes1, Sandra Piquet3, Sophie E. Polo 3, ✉ ✉ David R. FitzPatrick1, Wendy A. Bickmore 1 & Charlene Boumendil 1,4 Cornelia de Lange syndrome is a multisystem developmental disorder typically caused by mutations in the gene encoding the cohesin loader NIPBL. The associated phenotype is 1234567890():,; generally assumed to be the consequence of aberrant transcriptional regulation. Recently, we identified a missense mutation in BRD4 associated with a Cornelia de Lange-like syndrome that reduces BRD4 binding to acetylated histones. Here we show that, although this mutation reduces BRD4-occupancy at enhancers it does not affect transcription of the pluripotency network in mouse embryonic stem cells. Rather, it delays the cell cycle, increases DNA damage signalling, and perturbs regulation of DNA repair in mutant cells. This uncovers a role for BRD4 in DNA repair pathway choice. Furthermore, we find evidence of a similar increase in DNA damage signalling in cells derived from NIPBL-deficient individuals, suggesting that defective DNA damage signalling and repair is also a feature of typical Cornelia de Lange syndrome. 1 MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Crewe Road, Edinburgh, UK. 2 Blizard institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. 3 Epigenetics and Cell Fate Centre, UMR7216 CNRS, Université de Paris, ✉ Paris, France. 4 Université de Paris, CNRS, Institut Jacques Monod, Paris, France.
    [Show full text]
  • MAD2 (MAD2L1) Mouse Monoclonal Antibody [Clone ID: 17D10] Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA319545 MAD2 (MAD2L1) Mouse Monoclonal Antibody [Clone ID: 17D10] Product data: Product Type: Primary Antibodies Clone Name: 17D10 Applications: WB Recommend Dilution: ELISA: 1:5,000 - 1:20,000, WB: 1:200 - 1:2,000, IP: 1:100 Reactivity: Human Host: Mouse Clonality: Monoclonal Immunogen: This protein A purified monoclonal antibody was produced by repeated immunizations with full-length recombinant human MAD2L1 protein. Formulation: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 Concentration: 1 mg/ml Gene Name: MAD2 mitotic arrest deficient-like 1 (yeast) Database Link: NP_002349 Entrez Gene 4085 Human Synonyms: HSMAD2; MAD2 Note: MAD2L1 (also called mitotic spindle assembly checkpoint protein, MAD2A, MAD2-like 1 and HsMAD2) is a component of the mitotic spindle assembly checkpoint monitors the process of kinetochore-spindle attachment and delays the onset of anaphase when this process is not complete. MAD2L1 inhibits the activity of the anaphase-promoting complex by sequestering CDC20 until all chromosomes are aligned at the metaphase plate. MAD2L1 is related to the MAD2L2 gene located on chromosome 1. This protein has a nuclear localization. A MAD2 pseudogene has been mapped to chromosome 14 Protein Families: Druggable Genome Protein Pathways: Cell cycle, Oocyte meiosis, Progesterone-mediated oocyte maturation This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2020 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 MAD2 (MAD2L1) Mouse Monoclonal Antibody [Clone ID: 17D10] – TA319545 Product images: WB using anti-MAD2L1 antibody shows detection of a band at ~24 kDa (arrowhead) corresponding to MAD2L1 present in a HeLa whole cell lysate (lane 1).
    [Show full text]
  • Autocrine IFN Signaling Inducing Profibrotic Fibroblast Responses By
    Downloaded from http://www.jimmunol.org/ by guest on September 23, 2021 Inducing is online at: average * The Journal of Immunology , 11 of which you can access for free at: 2013; 191:2956-2966; Prepublished online 16 from submission to initial decision 4 weeks from acceptance to publication August 2013; doi: 10.4049/jimmunol.1300376 http://www.jimmunol.org/content/191/6/2956 A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Autocrine IFN Signaling Feng Fang, Kohtaro Ooka, Xiaoyong Sun, Ruchi Shah, Swati Bhattacharyya, Jun Wei and John Varga J Immunol cites 49 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2013/08/20/jimmunol.130037 6.DC1 This article http://www.jimmunol.org/content/191/6/2956.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 23, 2021. The Journal of Immunology A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Inducing Autocrine IFN Signaling Feng Fang,* Kohtaro Ooka,* Xiaoyong Sun,† Ruchi Shah,* Swati Bhattacharyya,* Jun Wei,* and John Varga* Activation of TLR3 by exogenous microbial ligands or endogenous injury-associated ligands leads to production of type I IFN.
    [Show full text]
  • DATASHEET USA: [email protected]
    DATASHEET USA: [email protected] FOR IN VITRO RESEARCH USE ONLY Europe: [email protected] NOT FOR USE IN HUMANS OR ANIMALS China: [email protected] MAD2L2 Polyclonal Anbody Catalog number: 12683-1-AP Background Size: 27 μg/150 μl MAD family, together with BUB and Mps1,Cdc20k, play roles in the mitoc spindle Source: Rabbit checkpoint. MAD2L2 is one of the MAD family. It can mediates the second Isotype: IgG polymerase switching in translaon DNA synthesis by mediang the inteacon Synonyms: between the error-prone DNA polymerase zeta catalyc subunit REV3L and the MAD2L2; hREV7, MAD2 like inserter polymerase REV1. Through regulaon of the JNK-mediated protein 2, MAD2B, MAD2L2, phosphorylaon and acvaon of the transcriponal acvator ELK1, MAD2L2 REV7, REV7 homolog involves in cellular response to DNA damage. Also it has role in the progression of cell cycle and peithelial-mesenchymal transdifferenaon. Applications Tested applicaons: ELISA, WB, IP Cited applicaons: WB Species specificity: Human,Mouse,Rat; other species not tested. Cited species: Human human brain ssue were subjected to Caculated MAD2L2 MW: 211aa,24 kDa SDS PAGE followed by western blot with 12683-1-AP(MAD2L2 anbody) Observed MAD2L2 MW: 24kd at diluon of 1:500 Posive WB detected in Human brain ssue, A375 cells, fetal human brain ssue, HEK-293 cells, HeLa cells, human colon ssue, human kidney ssue, K-562 cells, mouse brain ssue Posive IP detected in Mouse brain ssue Recommended diluon: WB: 1:500-1:5000 IP: 1:200-1:2000 Applicaon key: WB = Western blong, IHC = Immunohistochemistry, IF = Immunofluorescence, IP = Immunoprecipitaon IP Result of an-MAD2L2 (IP:12683- Immunogen information 1-AP, 3ug; Detecon:12683-1-AP 1:500) with mouse brain ssue lysate Immunogen: Ag3373 3600ug.
    [Show full text]
  • The Multifaceted Roles of the HOR MA Domain in Cellular Signaling
    JCB: Review The multifaceted roles of the HOR​MA domain in cellular signaling Scott C. Rosenberg1 and Kevin D. Corbett1,2 1Ludwig Institute for Cancer Research, San Diego Branch, La Jolla, CA 92093 2Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093 The HOR​MA domain is a multifunctional protein–protein 2004; Yang et al., 2007; Tipton et al., 2012; Eytan et al., 2014; interaction module found in diverse eukaryotic signaling Wang et al., 2014; Ye et al., 2015). Recently, two autophagy-sig- naling proteins, Atg13 and Atg101, were also shown to possess pathways including the spindle assembly checkpoint, nu- HOR​MA domains (Jao et al., 2013; Hegedűs et al., 2014; Su- merous DNA recombination/repair pathways, and the zuki et al., 2015a). In all of these different pathways, the role initiation of autophagy. In all of these pathways, HOR​MA of the HOR​MA domain is highly conserved, acting as a sig- domain proteins occupy key signaling junctures and func- nal-responsive adaptor mediating protein–protein interactions through a structurally unique mechanism. In this review, we tion through the controlled assembly and disassembly of will outline the general structure and interaction mechanisms of signaling complexes using a stereotypical “safety belt” the HOR​MA domain and discuss how these properties uniquely peptide interaction mechanism. A recent explosion of contribute to signaling in each family. Along the way, we will attempt to draw parallels between different HOR​MA domain structural and functional work has shed new light on these protein families, using lessons from well-understood systems proteins, illustrating how strikingly similar structural mech- such as Mad2 to inform our understanding of the others.
    [Show full text]